Literature DB >> 22615278

Inducible and constitutive activation of two polymorphic promoter alleles of the Candida albicans multidrug efflux pump MDR1.

Christoph Sasse1, Rebecca Schillig, Alexandra Reimund, Julia Merk, Joachim Morschhäuser.   

Abstract

Overexpression of the multidrug efflux pump MDR1 confers resistance to the antifungal drug fluconazole on Candida albicans. It has been reported that two types of MDR1 promoters exist in C. albicans and that homozygosity for the allele with higher activity may promote fluconazole resistance. We found that the two MDR1 promoter alleles in strain SC5314 were equally well activated by inducing chemicals or hyperactive forms of the transcription factors Mrr1 and Cap1, which control MDR1 expression. In addition, no loss of heterozygosity at the MDR1 locus was observed in MDR1-overexpressing clinical C. albicans strains that developed fluconazole resistance during therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22615278      PMCID: PMC3421547          DOI: 10.1128/AAC.00264-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

Review 1.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor.

Authors:  S Wirsching; S Michel; G Köhler; J Morschhäuser
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

3.  The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans.

Authors:  T C White
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

4.  Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.

Authors:  D Sanglard; F Ischer; M Monod; J Bille
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

5.  A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans.

Authors:  Alix Coste; Vincent Turner; Françoise Ischer; Joachim Morschhäuser; Anja Forche; Anna Selmecki; Judith Berman; Jacques Bille; Dominique Sanglard
Journal:  Genetics       Date:  2006-02-01       Impact factor: 4.562

6.  Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters.

Authors:  Mahir Karababa; Alix T Coste; Bénédicte Rognon; Jacques Bille; Dominique Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

7.  Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.

Authors:  R Franz; S L Kelly; D C Lamb; D E Kelly; M Ruhnke; J Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

8.  Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation.

Authors:  V Gupta; A Kohli; S Krishnamurthy; N Puri; S A Aalamgeer; S Panwar; R Prasad
Journal:  Curr Genet       Date:  1998-09       Impact factor: 3.886

9.  The diploid genome sequence of Candida albicans.

Authors:  Ted Jones; Nancy A Federspiel; Hiroji Chibana; Jan Dungan; Sue Kalman; B B Magee; George Newport; Yvonne R Thorstenson; Nina Agabian; P T Magee; Ronald W Davis; Stewart Scherer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

Review 10.  The genetic basis of fluconazole resistance development in Candida albicans.

Authors:  Joachim Morschhäuser
Journal:  Biochim Biophys Acta       Date:  2002-07-18
View more
  2 in total

1.  Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors.

Authors:  Sabrina Schneider; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

2.  Research of Mrr1, Cap1 and MDR1 in Candida albicans resistant to azole medications.

Authors:  Wenli Feng; Jing Yang; Lu Yang; Qing Li; Xin Zhu; Zhiqin Xi; Zusha Qiao; Wen Cen
Journal:  Exp Ther Med       Date:  2017-11-16       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.